WuXi Biologics (Cayman) Inc. provides end-to-end solutions and services for biologics discovery, development, and manufacturing in the People's Republic of China, North America, Europe, and internationally. It also engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and material supplier activities. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Stock data | 2024 | Change |
---|---|---|
Price | $1.44 | N/A |
Market Cap | $6.08B | N/A |
Shares Outstanding | 4.22B | N/A |
Employees | 12.40K | N/A |